Ihma

IHMA provides a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization. IHMA is a premier provider of antimicrobial drug development studies. With laboratories in both the US and Europe, we partner with clients around the world in the biotechnology, pharmaceutical, and diagnostic industries. We are a leading, independent laboratory specializing in surveillance studies and clinical trials, key milestones along the continuum from drug development to commercialization. We utilize state of the art technology, leading to first-class testing and data as well as sound economic frameworks. Our services can be customized to best align with our clients’ unique testing needs. This ensures successful drug development, commercialization, and post-marketing pathways.